Protagonist Therapeutics PTGX
NASDAQ PTGX
$140.97 -1.47 (-1.03%)
At close: Sep 29, 2026 · 4:00 PM EDT

Protagonist Therapeutics (PTGX) EBT Margin (2017 - 2026)

Updated

Protagonist Therapeutics' EBT Margin was 77.35% in Q2 2026, up 701.20 percentage points from -623.86% a year earlier and up 73.30 percentage points from the prior quarter.

Analysis

Protagonist Therapeutics (PTGX) EBT Margin (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Protagonist Therapeutics' EBT Margin was 29.91% through Jun 30, 2026, up 4.20 percentage points year-over-year; for FY2025, it was -281.01%, down 345.33 percentage points from FY2024.

  • EBT Margin shows a five-year change of -54.50 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was 64.32% in FY2024 (+195.91 pp), -131.59% in FY2023 (+347.67 pp), -479.26% in FY2022 (-20.33 pp) and -458.94% in FY2021 (-232.43 pp).
  • The Q2 2026 figure marks the highest quarterly EBT Margin since Q4 2024.
  • Compared with a year earlier, EBT Margin was higher in four of the last seven quarters, with an average year-over-year change of +0.11 percentage points.
  • The best year-over-year quarter for EBT Margin over five years was Q2 2026 (a gain of 701.20 percentage points); the worst was Q2 2022 (a drop of 3189.32 percentage points).
  • Per Business Quant data, PTGX's EBT Margin in the three quarters before Q2 2026 was 4.05% (Q1 2026), -587.84% (Q4 2025) and -834.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 26.66%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 25.18%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -4.11%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 29.63%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.19%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 27.53%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -131.41%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 41.75%
10 Protagonist Therapeutics 9.21 Bn 9.21 Bn - 77.35%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.35%
Mar 31, 2026 4.05%
Dec 31, 2025 -587.84%
Sep 30, 2025 -834.87%
Jun 30, 2025 -623.86%
Mar 31, 2025 -41.15%
Dec 31, 2024 78.33%
Sep 30, 2024 -719.36%
Jun 30, 2024 -750.95%
Mar 31, 2024 82.63%
Dec 31, 2023 45.56%
Jun 30, 2022 -4,551.00%
Mar 31, 2022 -81.42%
Dec 31, 2021 -428.30%
Sep 30, 2021 -328.64%
Jun 30, 2021 -1,361.68%
Mar 31, 2021 -387.75%
Dec 31, 2020 -334.27%
Sep 30, 2020 -59.20%
Jun 30, 2020 -294.23%
API Access

Protagonist Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=PTGX&period=max&api_key=YOUR_API_KEY